Abstract:Antibodies play a critical role in immunity against enterovirus 71 (EV71). However, how EV71-specific antibodies neutralize infections remains poorly understood. Here we report the working mechanism for a group of three monoclonal antibodies (MAbs) that potently neutralize EV71. We found that these three MAbs (termed D5, H7, and C4, respectively) recognize the same conserved neutralizing epitope within the VP1 GH loop of EV71. Single MAbs in this group, exemplified by D5, could inhibit EV71 infection in cell cultures at both the pre- and postattachment stages in a cell type-independent manner. Specifically, MAb treatment resulted in the blockade of multiple steps of EV71 entry, including virus attachment, internalization, and subsequent uncoating and RNA release. Furthermore, we show that the D5 and C4 antibodies can interfere with EV71 binding to its key receptors, including heparan sulfate, SCARB2, and PSGL-1, thus providing a possible explanation for the observed multi-inhibitory function of the MAbs. Collectively, our study unravels the mechanism of neutralization by a unique group of anti-EV71 MAbs targeting the conserved VP1 GH loop. The findings should enhance our understanding of MAb-mediated immunity against enterovirus infections and accelerate the development of MAb-based anti-EV71 therapeutic drugs. Importance: Enterovirus 71 (EV71) is a major causative agent of hand, foot, and mouth disease (HFMD), which has caused significant morbidities and mortalities in young children. Neither a vaccine nor an antiviral drug is available. Neutralizing antibodies are major protective components in EV71 immunity. Here, we unraveled an unusual mechanism of EV71 neutralization by a group of three neutralizing monoclonal antibodies (MAbs). All of these MAbs bound the same conserved epitope located at the VP1 GH loop of EV71. Interestingly, mechanistic studies showed that single antibodies in this MAb group could block EV71 attachment and internalization during the viral entry process and interfere with EV71 binding to heparan sulfate, SCARB2, and PSGL-1 molecules, which are key receptors involved in different steps of EV71 entry. Our findings greatly enhance the understanding of the interplays among EV71, neutralizing antibodies, and host receptors, which in turn should facilitate the development of an MAb-based anti-EV71 therapy.

Enhanced Human Enterovirus 71 Infection by Endocytosis Inhibitors Reveals Multiple Entry Pathways by Enterovirus Causing Hand-Foot-and-mouth Diseases

Increased frequency of circulating follicular helper T cells in children with hand, foot, and mouth disease caused by enterovirus 71 infection.

PATHOGEN SPECTRUM ANALYSIS OF HAND, FOOT AND MOUTH DISEASE AND GENETIC ANALYSIS OF THE VP1 REGION OF HUMAN ENTEROVIRUS 71 ISOLATED STRAINS IN HANGZHOU

Endophilin-A2-mediated Endocytic Pathway is Critical for Enterovirus 71 Entry into Caco-2 Cells.

Inhibition of ESCRT-independent Extracellular Vesicles Biogenesis Suppresses Enterovirus 71 Replication and Pathogenesis in Mice

Enterovirus 71 enters human brain microvascular endothelial cells through an ARF6-mediated endocytic pathway

Detection of human enterovirus 71 and coxsackievirus A16 in children with hand, foot and mouth disease in China.

The Pathogen of Enterovirus 71 on Hand-Foot-Mouth Disease Isolated and Identified

Inhibition of lysosome-tethered Ragulator-Rag-3D complex restricts the replication of Enterovirus 71 and Coxsackie A16

Activation of Host Cellular Signaling and Mechanism of Enterovirus 71 Viral Proteins Associated with Hand, Foot and Mouth Disease

Studies on Inhibition of Proliferation of Enterovirus-71 by Compound YZ-LY-0

The Molecule of DC-SIGN Captures Enterovirus 71 and Confers Dendritic Cell-Mediated Viral Trans-Infection

Enterovirus 71 infection of motor neuron-like NSC-34 cells undergoes a non-lytic exit pathway

Design, Synthesis, and Evaluation of Novel Enterovirus 71 Inhibitors As Therapeutic Drug Leads for the Treatment of Human Hand, Foot, and Mouth Disease.

Caspase-3 Inhibition Attenuates the Cytopathic Effects of EV71 Infection

Recent advances in the understanding of enterovirus A71 infection: a focus on neuropathogenesis

Single Neutralizing Monoclonal Antibodies Targeting the VP1 GH Loop of Enterovirus 71 Inhibit both Virus Attachment and Internalization during Viral Entry

Cooperative effect of the VP1 amino acids 98E, 145A and 169F in the productive infection of mouse cell lines by enterovirus 71 (BS strain)

The Endocytosis of Foot-and Mouth Disease Virus Requires Clathrin and Caveolin and is Dependent on the Existence of Rab5 and Rab7 in CHO-677 Cells

Association of viral replication capacity with the pathogenicity of enterovirus 71.

The pathogenesis during enterovirus 71-induced HFMD